Dermata Therapeutics, Inc.
DRMA • NASDAQ • Stock Fundamentals
Dermata Therapeutics, Inc. is a biotechnology company in the healthcare sector trading on NASDAQ, led by CEO Gerald T. Proehl, with a market cap of $4.9M.
Market Cap$4.9M
Employees8.0
CEOGerald T. Proehl
CountryUnited States of America
Healthcare
Biotechnology
Most Recent EarningsMay 13, 2026 · 15 days agoQ1 2026
View reportNext EarningsAug 18, 2026 · in 3 monthsBefore Market Open · Q2 2026
Financials
Based on Q1 2026 filing
Dermata Therapeutics, Inc. FAQ
Common questions about Dermata Therapeutics, Inc.
Dermata Therapeutics, Inc. (DRMA) has a market capitalization of $4.9M and trades on NASDAQ.
Dermata Therapeutics, Inc. has approximately 8 employees.